ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 186 filers reported holding ACHILLION PHARMACEUTICALS IN in Q4 2014. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $2,412,000 | +67.5% | 400,000 | 0.0% | 0.01% | +25.0% |
| Q3 2019 | $1,440,000 | +34.3% | 400,000 | 0.0% | 0.00% | +33.3% |
| Q2 2019 | $1,072,000 | -9.8% | 400,000 | -0.3% | 0.00% | 0.0% |
| Q1 2019 | $1,188,000 | +86.2% | 401,200 | 0.0% | 0.00% | +50.0% |
| Q4 2018 | $638,000 | -56.8% | 401,200 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $1,476,000 | +30.0% | 401,200 | 0.0% | 0.00% | +33.3% |
| Q2 2018 | $1,135,000 | -23.7% | 401,200 | 0.0% | 0.00% | -40.0% |
| Q1 2018 | $1,488,000 | +28.8% | 401,200 | 0.0% | 0.01% | +25.0% |
| Q4 2017 | $1,155,000 | -35.9% | 401,200 | 0.0% | 0.00% | -33.3% |
| Q3 2017 | $1,801,000 | -2.7% | 401,200 | -0.5% | 0.01% | -14.3% |
| Q2 2017 | $1,851,000 | +6.1% | 403,200 | -2.8% | 0.01% | 0.0% |
| Q1 2017 | $1,744,000 | -83.0% | 414,611 | -64.1% | 0.01% | -74.1% |
| Q2 2015 | $10,246,000 | +71.6% | 1,156,400 | +91.0% | 0.03% | -18.2% |
| Q1 2015 | $5,970,000 | -20.4% | 605,472 | -1.1% | 0.03% | -21.4% |
| Q4 2014 | $7,499,000 | +7.0% | 612,167 | -12.8% | 0.04% | -32.3% |
| Q3 2014 | $7,009,000 | – | 702,335 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 12,033,220 | $92,896,000 | 11.87% |
| RTW INVESTMENTS, LP | 2,558,859 | $19,754,000 | 7.17% |
| TURNER INVESTMENTS LLC | 859,560 | $6,636,000 | 1.80% |
| DAFNA Capital Management LLC | 236,500 | $1,826,000 | 1.58% |
| Ghost Tree Capital, LLC | 250,000 | $1,930,000 | 1.09% |
| Orbimed Advisors | 11,519,700 | $88,932,000 | 0.94% |
| Rock Springs Capital Management LP | 1,220,000 | $9,418,000 | 0.79% |
| Opus Point Partners Management, LLC | 99,000 | $764,000 | 0.59% |
| Bellevue Group AG | 420,000 | $3,242,000 | 0.59% |
| Cormorant Asset Management, LP | 500,000 | $3,860,000 | 0.58% |